Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection

Journal of Infectious Diseases

Volumn 187, Issue 5, 2003, Pages 748-757

  Lacabaratz Porret, Christine ^a,e   Urrutia, Alejandra ^a   Doisne, Jean Marc ^a   Goujard, Cécile ^a   Deveau, Christiane ^a   Dalod, Marc ^b,d   Meyer, Laurence ^a   Rouzieux, Christine ^c   Delfraissy, Jean François ^a   Venet, Alain ^a   Sinet, Martine ^a  

^a BICÊTRE HOSPITAL   (France)

^b INSERM U445 Hôpital Cochin ^*  (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VIREMIA; VIRUS LOAD;

ACUTE DISEASE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; VIRAL LOAD;

EID: 0037333799     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368333     Document Type: Article

References (31)

1. Malhotra U, Berrey MM, Huang Y, et al. Effect of combination antiretroviral therapy on T cell immunity in acute human immunodeficiency virus type 1 infection. J Infect Dis 2000; 181:121-31.
2. Berrey MM, Schacker T, Collier AC, et al. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis 2001; 183:1466-75.
3. Goujard C, Boufassa F, Deveau C, Laskri D, Meyer L. Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infection. AIDS 2001; 15:282-4.
4. + T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
5. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-80.
6. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T Iymphocytes and plasma load of viral RNA. Science 1998; 279:2103-6.
7. Dalod M, Harzic M, Pellegrin I, et al. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis 1998; 178:61-9.
8. + T-cell effector activity in HIV primary infection. J Clin Invest 1999; 104:1431-9.
9. + T lymphocytes. Proc Natl Acad Sci USA 2000; 97:3382-7.
10. + T cell responses associated with control of viremia. Science 1997; 278:1447-50.
11. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
12. Musey LK, Krieger JN, Hughes JP, Schacker TW, Corey L, McElrath MJ. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J Infect Dis 1999; 180:278-84.
13. Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS 2000; 14:761-70.
14. Angel JB, Parato KG, Kumar A, et al. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. J Infect Dis 2001; 183:546-54.
15. Blankson JN, Gallant JE, Siliciano RF. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution. J Infect Dis 2001; 183:657-61.
16. + T cell proliferation. Proc Natl Acad Sci USA 2001; 98:13878-83.
17. + T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J Virol 2002; 76:5925-36.
18. - T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-γ and interleukin-10 responses. J Infect Dis 2001; 184:1268-78.
19. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-7.
20. Goulder PJ, Altfeld MA, Rosenberg ES, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001; 193:181-94.
21. Ogg GS, Kostense S, Klein MR, et al. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J Virol 1999; 73:9153-60.
22. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 1999; 162:1780-8.
23. + responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol 1999; 73:7108-16.
24. Kalams SA, Buchbinder SP, Rosenberg ES, et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 1999; 73:6715-20.
25. + T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol 2001; 75:6508-16.
26. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188:2205-13.
27. + T cells. J Virol 2000; 74:1018-22.
28. + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
29. Goepfert PA, Bansal A, Edwards BH, et al. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 2000; 74:10249-55.
30. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
31. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-6.